Alectinib as a treatment option following recovery from crizotinib‑induced interstitial lung disease in patients with anaplastic lymphoma kinase‑positive�advanced non‑small‑cell lung cancer
Nukaga, Shigenari, Naoki, Katsuhiko, Kamo, Tetsuro, Masuzawa, Keita, Yasuda, Hiroyuki, Soejima, Kenzo, Betsuyaku, TomokoМова:
english
Журнал:
Molecular and Clinical Oncology
DOI:
10.3892/mco.2016.838
Date:
March, 2016
Файл:
PDF, 345 KB
english, 2016
File converter
Більше результатів пошуку
More benefits 
